HomeLXEO • NASDAQ
add
Lexeo Therapeutics Inc
Previous close
$6.20
Day range
$6.20 - $6.72
Year range
$5.77 - $22.33
Market cap
213.90M USD
Avg Volume
538.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.12M | 168.25% |
Net income | -29.49M | -46.65% |
Net profit margin | — | — |
Earnings per share | -0.89 | 25.83% |
EBITDA | -31.38M | -56.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 157.02M | 342.95% |
Total assets | 173.86M | 217.71% |
Total liabilities | 34.54M | 6.28% |
Total equity | 139.33M | — |
Shares outstanding | 33.07M | — |
Price to book | 1.47 | — |
Return on assets | -43.11% | — |
Return on capital | -48.45% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -29.49M | -46.65% |
Cash from operations | -17.81M | -27.65% |
Cash from investing | -83.00K | -56.60% |
Cash from financing | -72.00K | -101.84% |
Net change in cash | -17.96M | -78.01% |
Free cash flow | -7.86M | -25.78% |
About
Founded
2017
Website
Employees
72
